[breadcrumb_custom]

Tag: PRQR Stock

News

ProQR Therapeutics N.V Inc. (PRQR) Price Performance: A Comparative Analysis with Competitors

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price decrease of -2.53%. However, over the past six months, we’ve seen a weaker performance of 25.32%. The price of PRQR leaped by -22.80% over the last 30 days. And in the last five days, it has fallen by -6.31%. ProQR Therapeutics N.V had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $3.85

Stock

ProQR Therapeutics N.V (PRQR) Stock: 52-Week Performance Insights and Trading Volume

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. ProQR Therapeutics N.V’s current trading price is -49.61% away from its 52-week high, while its distance from the 52-week low is 74.77%. The stock’s price range for this period has been between $1.11 and $3.85 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.9 million for the day, a number notably higher than the average daily volume of 0.3 million over the last three months. In terms of market performance, ProQR Therapeutics

Industry

ProQR Therapeutics N.V Inc. (PRQR) Price Performance: A Comparative Analysis with Competitors

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Until today this year the stock’s price performance recorded an increase of 26.26%. However, over the last six months, the performance has been weaker by 47.06%. The price of PRQR increased 22.55% over the last 30 days. And in the last five days, it has surged by 25.63%. ProQR Therapeutics N.V’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $3.85 on 03/21/23, with

Equity News

How Did The ProQR Therapeutics (PRQR) Stock Rise 35% Pre-Hours?

After the company announced an expansion of cooperation, shares of ProQR Therapeutics N.V. (Nasdaq: PRQR) were up 35.15% at $2.23 at the time of our last check in pre-market trading. What partnership will PRQR be extending? Eli Lilly and Company (NYSE: LLY) and ProQR Therapeutics (PRQR) have expanded their license and partnership arrangement to concentrate more on the research and marketing of novel genetic treatments. The partnership, which was first disclosed in September 2021, used ProQR Therapeutics’ exclusive Axiomer RNA editing tool to treat liver and nervous system diseases. Since the beginning of the project, platform improvements have greatly improved